Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-03-17

FDA Approved: FLUCONAZOLE — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved a supplemental application for fluconazole submitted by Rising Pharma Holdings, Inc., indicating approval of a generic formulation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluconazole (generic) (Fluconazole)

Snippet

SUPPL AP for FLUCONAZOLE (FLUCONAZOLE)